From 1 June 2015, Professor Maarten IJzerman will take up the role of deputy dean of Health and Biomedical Technology at the Faculty of Science and Technology. This appointment is part of the University of Twente’s strategy to strengthen and expand its medical technology profile.
In his new role, Professor IJzerman’s portfolio will include the Health and Biomedical Technology cluster, which takes in the Science and Technology chairs affiliated with the MIRA institute and the degree programmes in Technical Medicine and Biomedical Technology. He will also help shape the university’s strategy in the field of Health and Biomedical Technology, with a particular focus on internationalization and the new housing plans for the Health cluster. The position of deputy dean is under the auspices of the Faculty of Science and Technology and Professor IJzerman will become a member of the faculty management team led by Dean Hans Hilgenkamp.
In addition to his work as deputy dean, Professor IJzerman will continue his affiliation with the Chair of Health Technology & Services Research within the Faculty of Behavioural, Management and Social Sciences and with the Health Sciences degree programme.
About Maarten IJzerman
Maarten IJzerman graduated in Biomedical Sciences at the Medical Faculty of Radboud University Nijmegen, after which he embarked on PhD research with the Chair of Biosignals and Systems (Faculty of EEMCS) at the Biomedical Technology Institute (which later became MIRA). His research focused on the development of neuroprosthetics for people with spinal cord injuries. After obtaining his doctorate, he became research coordinator at the Medical Faculty of VU University Amsterdam and adjunct clinical professor at Case Western Reserve University, Cleveland, Ohio, USA. In 2000 he became scientific director of Roessingh Research and Development, followed in 2003 by a two-year appointment at the Faculty of Science and Technology as a member of the Technical Medicine curriculum committee. Two years later, he went on to become professor at the Faculty of EEMCS and since 2007 he has worked at the Faculty of Management and Governance, charged with the task of setting up the Health Sciences programme and related research with a strong medical-technical profile. From 2013 to 2014, he fulfilled the role of acting Scientific Director at MIRA.
His primary field of interest is medical technology research, with a special focus on molecular diagnostics and personalized medicine. From that perspective, he is involved in several major international partnerships, such as the Centre for Personalized Cancer Treatment (CPCT), the Global Initiative for Translational Health Economics and the 100,000 Genomes Initiative in the UK. In the international arena, he is very active as a member of the Board of Directors of the International Society for Pharmacoeconomics, where he was recently appointed president-elect.
